this issue
previous article in this issuenext article in this issue

Document Details :

Title: Association of coronary atherosclerosis with insulin resistance in patients with impaired glucose tolerance
Author(s): STOCHMAL, Ewa , SZURKOWSKA, Magdalena , CZARNECKA, Dunata , STOCHMAL, Anna , KLECHA, Artur , KAWECA-JASZCZ, Kalina , SZYBINSKI, Zbigniew
Journal: Acta Cardiologica
Volume: 60    Issue: 3   Date: June 2005   
Pages: 325-331
DOI: 10.2143/AC.60.3.2005012

Abstract :
Objectives — The purpose of the study was to evaluate the role of insulin resistance (IR) in the development of coronary atherosclerosis in patients with impaired glucose tolerance.

Methods and results — The study group consisted of 42 patients with impaired glucose tolerance. Based upon coronary angiography the patients were divided into group A – with prior myocardial infarction and critical coronary stenosis (n = 20) and group B – without prior myocardial infarction and without critical coronary stenosis (n = 22).
In each patient glucose disposal rate (GDR) during metabolic clamp, insulinaemia in the fasting state and during the clamp, glycaemia during oral glucose tolerance test (OGTT), BMI and body mass composition were measured. The groups did not differ in age, BMI, percent fat content and distribution, and blood pressure.
Fasting insulinaemia (56.7 mU/ ml) was higher in group A than in group B (22.3 mU/ml). GDR in group A (2.96 mg/kg b.m./min) was lower than in group B (5.36 mg/kg b.m./min). There was a negative correlation between the number of critically narrowed coronary vessels and GDR in group A. GDR below 3.97 mg/kg b.m./min was found, based on regression analysis, to be a powerful risk factor for myocardial infarction.

Conclusions — The relationship between IR and severity of coronary atherosclerosis implies its unfavourable role in the development of atherosclerosis. The present findings indicate a negative role of IR in the development of myocardial infarction and suggest that it is an independent risk factor, which identifies high-risk patients requiring treatment that would increase tissue insulin sensitivity.